VopF, a type III effector protein from a non-O1, non-O139 Vibrio cholerae strain, demonstrates toxicity in a Saccharomyces cerevisiae model

Journal of Medical Microbiology

Volumn 59, Issue 1, 2010, Pages 17-24

  Tripathi, Ranjana ^a   Naorem, Santa Singh ^a   Dureja, Chetna ^a   Haldar, Swati ^a   Mondal, Alok K ^a   Raychaudhuri, Saumya ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; UNCLASSIFIED DRUG; VOPF PROTEIN;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SACCHAROMYCES CEREVISIAE; TOXICITY; VIBRIO CHOLERAE;

BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; SACCHAROMYCES CEREVISIAE; VIBRIO CHOLERAE NON-O1; VIRULENCE; VIRULENCE FACTORS;

EID: 73649143116     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.012336-0     Document Type: Article

References (27)

1. Arnoldo, A., Curak, J., Kittanakom, S., Chevelev, I., Lee, V. T., Sahebol-Amri, M., Koscik, B., Ljuma, L., Roy, P. J. & other authors (2008). Identification of small molecule inhibitors of Pseudomonas aeruginosa Exoenzyme S using a yeast phenotypic screen. PLoS Genet 4, e1000005.
2. Chen, Y., Johnson, J. A., Pusch, G. D., Morris, J. G., Jr & Stine, O. C. (2007). The genome of non-O1 Vibrio cholerae NRT 36S demonstrates the presence of pathogenic mechanisms that are distinct from O1 Vibrio cholerae. Infect Immun 75, 2645-2647.
3. Dean, P., Maresca, M. & Kenny, B. (2005). EPEC's weapons of mass subversion. Curr Opin Microbiol 8, 28-34.
4. Dziejman, M., Serruto, D., Tam, V. C., Sturtevant, D., Diraphat, P., Faruque, S. M., Rahman, H. M., Heidelberg, J. F., Decker, J. & other authors (2005). Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system. Proc Natl Acad Sci U S A 102, 3465-3470.
5. Hassane, D. C., Lee, R. B., Mendenhall, M. D. & Pickett, C. L. (2001). Cytolethal distending toxin demonstrates genotoxic activity in a yeast model. Infect Immun 69, 5752-5759.
6. Hayward, R. D. & Koronakis, V. (2002). Direct modulation of the host cell cytoskeleton by Salmonella actin-binding proteins. Trends Cell Biol 12, 15-20.
7. Huang, J., Lesser, C. F. & Lory, S. (2008). The essential role of the CopN protein in Chlamydia pneumoniae intracellular growth. Nature 456, 112-115.
8. Jewett, T. J., Fischer, E. R., Mead, D. J. & Hackstadt, T. (2006). Chlamydia TARP is a bacterial nucleator of actin. Proc Natl Acad Sci U S A 103, 15599-15604.
9. Joelsson, A., Liu, Z. & Zhu, J. (2006). Genetic and phenotypic diversity of quorum sensing systems in clinical and environmental isolates of Vibrio cholerae. Infect Immun 74, 1141-1147.
10. Lesser, C. F. & Miller, S. I. (2001). Expression of microbial virulence proteins in Saccharomyces cerevisiae models mammalian infection. EMBO J 20, 1840-1849.
11. Liverman, A. D. B., Cheng, H.-C., Trosky, J. E., Leung, D. W., Yarbrough, M. L., Burdette, D. L., Rosen, M. K. & Orth, K. (2007). Arp2/3-independent assembly of actin by Vibrio type III effector VopL. Proc Natl Acad Sci U S A 104, 17117-17122.
12. McMillan, J. N., Sia, R. A. L. & Lew, D. J. (1998). A morphogenesis checkpoint monitors the actin cytoskeleton in yeast. J Cell Biol 142, 1487-1499.
13. Nejedlik, L., Pierfelice, T. & Geiser, J. R. (2004). Actin distribution is disrupted upon expression of Yersinia YopO/YpkA in yeast. Yeast 21, 759-768.
14. Quinlan, M. E., Heuser, J. A., Kerkhoff, E. & Mullins, R. D. (2005). Drosophila Spire is an actin nucleation factor. Nature 433, 382-388.
15. Rabin, S. D. & Hauser, A. R. (2003). Pseudomonas aeruginosa ExoU, a toxin transported by the type III secretion system, kills Saccharomyces cerevisiae. Infect Immun 71, 4144-4150.
16. Raychaudhuri, S., Jain, V. & Dongre, M. (2006). The identification of a constitutively active variant of LuxO that affects the production of HA/protease and biofilm development in a non-O1, non-O139 strain Vibrio cholerae O110. Gene 369, 126-133.
17. Rodríguez-Escudero, I., Hardwidge, P. R., Nombela, C., Cid, V. J., Finlay, B. B. & Molina, M. (2005). Enteropathogenic Escherichia coli type III effectors alter cytoskeletal function and signaling in Saccharomyces cerevisiae. Microbiology 151, 2933-2945.
18. Rodríguez-Pachón, J. M., Martín, H., North, G., Rotger, R., Nombela, C. & Molina, M. (2002). A novel connection between the yeast Cdc42 GTPase and the Slt2-mediated cell integrity pathway identified through the effect of secreted Salmonella GTPase modulators. J Biol Chem 277, 27094-27102.
19. Sato, H., Frank, D. W., Hillard, C. J., Feix, J. B., Pankhaniya, R. R., Moriyama, K., Finck-Barbancon, V., Buchaklian, A., Lei, M. & other authors (2003). The mechanism of action of the Pseudomonas aeruginosa encoded type III cytotoxin, ExoU. EMBO J 22, 2959-2969.
20. Shohdy, N., Efe, J. A., Emr, S. D. & Shuman, H. A. (2005). Pathogen effector protein screening in yeast identifies Legionella factors that interfere with membrane trafficking. Proc Natl Acad Sci U S A 102, 4866-4871.
21. Sturgill, T. W., Cohen, A., Diefenbacher, M., Trautwein, M., Martin, D. E. & Hall, M. N. (2008). Tor1 and Tor2 have distinct locations in live cells. Eukaryot Cell 7, 1819-1830.
22. Tam, V. C., Serruto, D., Dziejman, M., Brieher, W. & Mekalanos, J. J. (2007). A type III secretion system in Vibrio cholerae translocates a formin/spire hybrid-like actin nucleator to promote intestinal colonization. Cell Host Microbe 1, 95-107.
23. Tran Van Nhieu, G., Caron, E., Hall, A. & Sansonetti, P. J. (1999). IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells. EMBO J 18, 3249-3262.
24. Trosky, J. E., Mukherjee, S., Burdette, D. L., Roberts, M., McCarter, L., Siegel, R. M. & Orth, K. (2004). Inhibition of MAPK signaling pathways by VopA from Vibrio parahaemolyticus. J Biol Chem 279, 51953-51957.
25. Valdivia, R. H. (2004). Modeling the function of bacterial virulence factors in Saccharomyces cerevisiae. Eukaryot Cell 3, 827-834.
26. Von Pawel-Rammingen, U., Telepnev, M. V., Schmidt, G., Aktories, K., Wolf-Watz, H. & Rosqvist, R. (2000). GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol Microbiol 36, 737-748.
27. Yoon, S., Liu, Z., Eyobo, Y. & Orth, K. (2003). Yersinia effector YopJ inhibits yeast MAPK signaling pathways by an evolutionarily conserved mechanism. J Biol Chem 278, 2131-2135.